Free Trial
NASDAQ:BDMD

Baird Medical Investment (BDMD) Stock Price, News & Analysis

Baird Medical Investment logo
$1.82 +0.02 (+1.11%)
Closing price 04:00 PM Eastern
Extended Trading
$1.82 +0.00 (+0.27%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Baird Medical Investment Stock (NASDAQ:BDMD)

Advanced

Key Stats

Today's Range
$1.75
$2.00
50-Day Range
$1.68
$3.44
52-Week Range
$0.76
$7.26
Volume
365,086 shs
Average Volume
246,756 shs
Market Capitalization
$74.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Baird Medical Investment Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

BDMD MarketRank™: 

Baird Medical Investment scored higher than 11% of companies evaluated by MarketBeat, and ranked 815th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Baird Medical Investment has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Baird Medical Investment has only been the subject of 1 research reports in the past 90 days.

  • Read more about Baird Medical Investment's stock forecast and price target.
    • Percentage of Shares Shorted

      5.92% of the float of Baird Medical Investment has been sold short.
    • Short Interest Ratio / Days to Cover

      Baird Medical Investment has a short interest ratio ("days to cover") of 1.19, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in Baird Medical Investment has recently decreased by 46.64%, indicating that investor sentiment is improving significantly.
    • Dividend Yield

      Baird Medical Investment does not currently pay a dividend.

    • Dividend Growth

      Baird Medical Investment does not have a long track record of dividend growth.

    • News Coverage This Week

      MarketBeat has tracked 2 news articles for Baird Medical Investment this week, compared to 1 article on an average week.
    • Search Interest

      Only 2 people have searched for BDMD on MarketBeat in the last 30 days. This is a decrease of -78% compared to the previous 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, Baird Medical Investment insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      78.90% of the stock of Baird Medical Investment is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      19.78% of the stock of Baird Medical Investment is held by institutions.

    • Read more about Baird Medical Investment's insider trading history.
    Receive BDMD Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Baird Medical Investment and its competitors with MarketBeat's FREE daily newsletter.

    SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    BDMD Stock News Headlines

    You’re Being LIED To About The Iran War
    The mainstream explanation for the Iran airstrikes may not be the full story. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there's a deeper motive behind the bombing campaign that most coverage is ignoring. If you're making investment decisions based on what you're hearing in the news, Wiggin argues you could be working with an incomplete picture.tc pixel
    Baird Medical Investment Holdings Ltd
    See More Headlines

    BDMD Stock Analysis - Frequently Asked Questions

    Baird Medical Investment's stock was trading at $1.36 at the beginning of the year. Since then, BDMD stock has increased by 33.8% and is now trading at $1.82.

    Shares of BDMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Baird Medical Investment investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), Baidu (BIDU).

    Company Calendar

    Today
    5/05/2026
    Fiscal Year End
    12/31/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED INSTRUMENTS
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:BDMD
    Previous Symbol
    NASDAQ:BDMD
    CIK
    1982444
    Web
    N/A
    Fax
    N/A
    Employees
    N/A
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    N/A
    Quick Ratio
    N/A

    Sales & Book Value

    Annual Sales
    $22.54 million
    Price / Sales
    3.31
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    N/A
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    40,980,000
    Free Float
    8,647,000
    Market Cap
    $74.58 million
    Optionable
    N/A
    Beta
    -1.18
    Analysts Agree—These Gold Picks Outshine the Rest Cover

    Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

    Get This Free Report

    This page (NASDAQ:BDMD) was last updated on 5/5/2026 by MarketBeat.com Staff.
    From Our Partners